|
Shatalova N.A., Mirzaev K.B., Abdullaev Sh.P., Sozaeva Zh.A., Bochkov P.O., Asoskova A.V., Denisenko N.P., Kochetkov A.I., Ebzeeva E.Yu., Chernyaeva M.S., Shastina V.R., Ostroumova O.D., Sychev D.A.
On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease
|
№1 / 2024
|
|
T.N. Trofimtseva, S.K. Yarovoy, A.A. Gritskevich
Prevalence of chronic kidney disease among cancer patients
|
№11 / 2023
|
|
T.N. Trofimtseva, S.K. Yarovoy, A.A. Gritskevich, T.P. Baytman
Efficacy of the combination of pembrolizumab and axitinib in the treatment of renal cell carcinoma associated with chronic kidney disease
|
№11 / 2023
|
|
G.G. Allamova, O.D. Dygun, B.G. Lukichev, L.A. Belyakova, Yu.S. Mikheeva, A.R. Volkova
The functional state of the thyroid gland in patients with end-stage renal disease on program hemodialysis
|
№3 / 2023
|
|
T.P. Makarova, L.A. Davlieva, Yu.S. Melnikova, D.R. Khusnutdinova
Endothelial dysfunction indicators in children with hemolytic-uremic syndrome
|
№1-2 / 2023
|
|
B.G. Iskenderov, A.V. Zaitseva, I.N. Mozhzhukhin, M.G. Ivanchukova
Impact of coronary artery stenting on the course of chronic kidney disease in patients with stable angina
|
№13 / 2022
|
|
A.F. Verbovoy, N.I. Verbovaya, L.A. Sharonova
Hypothyroidism is an untimely diagnosed disease
|
№11-12 / 2022
|
|
I.M. Abramova, K.V. Azizova, O.D. Dygun, A.D. Orlovskaya
Replacement therapy of subclinical hypothyroidism in patients with various stages of chronic kidney disease
|
№4 / 2022
|
|
M.B. Antsiferov (1), O.M. Koteshkova (1), M.S. Novikova (1), N.A. Demidov (2)
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
|
№12 / 2021
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), S.V. Batyukina (1), N.L. Lyakhova (3)
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
|
№3 / 2020
|
|
A.I. Dyadyk, Т.Е. Kugler, E.V. Schukina, I.V. Rakitskaya, S.R. Zborovsky, Yu.V. Suliman
DIURETHIC RESISTANCE: MECHANISMS, MEDICAL TACTICS AND PREVENTION
|
№18 / 2017
|
|
I.T. Murkamilov (1, 2), K.A. Aitbayev (3), V.V. Fomin (4), Z.R. Rayimzhanov (5), N.A. Redzhapova (6), F.A. Yusupov (6), Z.A. Aydarov (1)
SUPPRESSION OF PROGRESSION OF RENAL DYSFUNCTION AND CEREBROVASCULAR EVENTS: POTENTIALS OF ATORVASTATIN
|
№15 / 2017
|
Русский
